Apollo Global Management (APO) — Q2 2026 Earnings Preview

Company

Apollo Global Management, Inc.

Earnings Date

August 4, 2026 (Pre-Market)

Ticker

APO (NYSE)

Reporting Period

Q2 2026 (April 1 – June 30, 2026)

Prepared

August 3, 2026

Earnings Call

August 4, 2026 — 8:30 AM ET

1. Earnings Preview

Key Takeaway: The setup favors a beat on FRE — the highest-conviction metric — with the bigger swing factor being whether SRE recovers meaningfully from Q1’s depressed 97 bps net spread after management guided to 120–125 bps for the full year; the July 1 pre-announcement of ~$350M in Q2 alternative net investment income (implying a ~9% annualized alts return) is a clear positive signal but still below the 11% full-year assumption embedded in guidance.

Apollo heads into Q2 2026 earnings with a constructive but not euphoric setup. Consensus FRE of ~$767M implies roughly 20% year-over-year growth, squarely in line with management’s reaffirmed “20%-plus” target, making the bar achievable but not easy to clear given the record $728M Q1 print. On SRE, the July 1 pre-announcement of ~$350M in Q2 alternative net investment income (9% annualized return) is a step up from Q1’s 6% alts return, but still trails the 11% full-year assumption, meaning the Street’s ~$874M SRE consensus likely requires a clean core spread result to be met. Management’s tone since Q1 has been incrementally positive — Marc Rowan flagged Q2 origination could approach the all-time record $97B quarter, Athene reported strong April/May retail and flow reinsurance volumes, and the HECS pipeline was described as the deepest in firm history — all of which support FRE upside through ACS fees. Estimate revisions have drifted modestly lower since the Q1 print (FRE consensus down ~$4M, SRE down ~$41M from the post-Q1 baseline), suggesting the Street has absorbed the alts headwind but not fully priced in the origination upside. The stock is down ~9% since the May 6 earnings date versus SPY flat, trading at roughly 12.7x NTM earnings — a compressed multiple that reflects lingering private credit sentiment concerns rather than fundamental deterioration. The key wildcard is the magnitude of Q2 origination: if Apollo delivers near or above the $97B record, ACS fees could materially exceed the ~$250M consensus, driving a meaningful FRE beat and likely re-rating the stock.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus sets a achievable but not low bar on FRE (~$767M, +20% YoY) while SRE (~$874M) is the bigger swing factor — the July 1 pre-announcement of ~9% alts return vs. the 11% full-year assumption means SRE could miss unless core spread performance is clean; ACS fees are the upside lever if origination approaches the record $97B quarter.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual

Q2 2026 Consensus

YoY Change

Guidance

Cons. vs. Guidance

Fee-Related Earnings (FRE)

$728M

$627M

$767M

+22% YoY

20%+ FY2026 growth

In line with target

Spread-Related Earnings (SRE)

$719M

$821M

$874M

+6% YoY

10% FY2026 growth (11% alts return)

~3% below implied run-rate

Distributable EPS – Operating

$1.94

$1.92

$2.16

+13% YoY

~$8.84 FY2026 consensus

In line

End-of-Period AUM

$1,026B

$840B

$1,056B

+26% YoY

Solidly north of $150B annual inflows

On track

Gross Capital Deployment (Origination)

$103B

$90B

$97B

+8% YoY

Q2 “even stronger” than Q1; record ~$97B possible

Consensus may be conservative

Net Spread – RS (Operating)

97 bps (adj. ~122 bps)

N/A — not separately disclosed

N/A — not in VA

N/A

120–125 bps FY2026

Q1 adj. in range; Q2 alts ~9% vs. 11% target

Sources: Visible Alpha Consensus and Actuals Data (FRE, SRE, Distributable EPS – Operating, End-of-Period AUM, Gross Capital Deployment); Apollo Q1 2026 Earnings Call (May 6, 2026); Apollo 8-K Pre-Announcement (July 1, 2026).

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

Quarter

FRE Reported

FRE Consensus

FRE Surprise

SRE Reported

SRE Consensus

SRE Surprise

Q1 2026

$728M

$692M

+5.2%

$719M

$735M

-2.2%

Q4 2025

$690M

$673M

+2.5%

$865M

$852M

+1.5%

Q3 2025

$652M

$627M

+4.0%

$871M

$826M

+5.5%

Q2 2025

$627M

$578M

+8.5%

$821M

$803M

+2.2%

Q1 2025

$559M

$549M

+1.8%

$804M

$825M

-2.5%

Q4 2024

$554M

$550M

+0.7%

$841M

$853M

-1.4%

Q3 2024

$531M

$518M

+2.5%

$856M

$769M

+11.3%

Q2 2024

N/A — not in VA

N/A

N/A

N/A — not in VA

N/A

N/A

Pattern: Apollo has beaten FRE consensus in every reported quarter, with beats ranging from +0.7% to +8.5%, reflecting consistent management fee and ACS fee outperformance; SRE is more volatile, with misses in Q1 2026, Q1 2025, and Q4 2024 driven by alts portfolio underperformance and spread headwinds, while beats in Q3 2024 and Q3 2025 were driven by alts outperformance.

Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Management’s posture has been incrementally more confident since Q1 — the July 1 pre-announcement of ~$350M Q2 alts income and Athene’s May 15 investor call confirming strong April/May retail flows both signal the business is tracking ahead of Q1’s depressed alts result, though the 11% full-year alts assumption remains a stretch; FRE guidance is unchanged and well-supported by the origination pipeline.

Metric

Initial Guidance (Q1 2026 Earnings Call — May 6, 2026)

Revised Guidance

Current Consensus

Note

FRE Growth (FY2026)

20%+ year-over-year

$3.11B (+20% YoY)

Unchanged; management expressed confidence in strong inflows and robust origination pipeline

SRE Growth (FY2026)

10% growth, assuming 11% alts return

$3.48B

Unchanged; Q2 alts pre-announced at ~9% annualized (July 1 8-K) — below 11% target but better than Q1’s 6%; tone improving

Net Spread – RS (FY2026)

120–125 bps (assuming 11% alts return)

N/A — not in VA

Unchanged; Q1 adjusted spread was ~122 bps (in range); Q2 alts at 9% implies spread will be below 120 bps reported but management likely to adjust for alts shortfall

Q2 Origination

“Even stronger” than Q1 ($103B); record $97B possible

~$97B consensus

Unchanged; Athene May 15 call confirmed strong April/May retail and flow reinsurance; HECS pipeline described as deepest in firm history

Q2 Alts Net Investment Income

11% annualized return assumed for FY2026

~$350M pre-tax (~9% annualized) — July 1, 2026 8-K

~$874M SRE (incorporates alts pre-announcement)

↑ Positive update vs. Q1’s 6%; pooled vehicle returned ~10%, other alts ~6%; below 11% FY target but improving trajectory

Athene New Markets (FY2026)

>$5B for the year; ultimately ~50% of new business

N/A

Unchanged; Q1 exceeded $1B for first time; May 15 call confirmed strong April/May retail ($3.7B in April alone) and flow reinsurance momentum

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have drifted modestly lower since the Q1 print — Q2 FRE consensus is down ~$3M and SRE down ~$41M from the post-earnings baseline — suggesting the Street absorbed the alts headwind but has not yet priced in the origination upside; the gap between SRE consensus and guidance implies SRE is the risk, not the cushion, while FRE estimates are tracking guidance well.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (May 13, 2026)

Current Consensus (Aug 3, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

FRE (Q2 2026)

$769M

$767M

-0.3%

20%+ FY growth

Unchanged

In line with target

FRE (FY2026)

$3,114M

$3,109M

-0.2%

20%+ growth

Unchanged

In line

SRE (Q2 2026)

$915M

$874M

-4.5%

10% FY growth (11% alts)

Q2 alts pre-announced ~9% (July 1 8-K)

Alts below target

~3% below implied quarterly run-rate

SRE (FY2026)

$3,569M

$3,483M

-2.4%

10% growth

Unchanged

~2% below guidance midpoint

Distributable EPS – Operating (Q2 2026)

$2.21

$2.16

-2.3%

~$8.84 FY consensus

Unchanged

In line

Distributable EPS – Operating (FY2026)

$9.02

$8.84

-2.0%

N/A (no explicit EPS guidance)

Unchanged

N/A

The most notable revision is the ~$41M (4.5%) downward move in Q2 SRE consensus since the Q1 print, driven by the Street incorporating the July 1 pre-announcement of ~9% alts return vs. the 11% full-year assumption. FRE estimates have been remarkably stable (−0.3%), consistent with management’s unchanged 20%+ growth guidance and the strong origination pipeline commentary. The SRE gap represents a risk rather than a cushion heading into the print.

Source: Visible Alpha Consensus and Actuals Data (revision history table, weekly frequency, May 8 – August 3, 2026); Apollo 8-K (July 1, 2026).

5. Stock Performance

Key Takeaway: APO has significantly underperformed since the Q1 earnings date — down ~9% vs. SPY roughly flat and KKR down ~6% — driven almost entirely by multiple compression (NTM P/E contracted from ~16.9x to ~12.7x over the past 12 months) rather than estimate cuts, as private credit sentiment headwinds and BDC redemption concerns weighed on the sector; the stock’s underperformance vs. SPY is a sentiment discount, not a fundamental one, and a clean Q2 print could catalyze a re-rating.

APO vs. KKR vs. KIE vs. SPY — Indexed Performance Since Q1 2026 Earnings (May 6, 2026)

Ticker

May 6, 2026 Close

Aug 3, 2026 Close*

Return Since Q1 Earnings

Peak (Period)

Trough (Period)

APO

$129.53

$125.59 (Jul 31)

-3.0%

$138.91 (Jun 17)

$114.83 (Jun 29)

KKR

$100.79

$101.43 (Jul 31)

+0.6%

$102.75 (Jul 16)

$88.94 (Jun 29)

KIE (Insurance ETF)

$56.35

$64.24 (Jul 31)

+13.9%

$66.45 (Jul 28)

$54.24 (Jun 3)

SPY (S&P 500)

$733.83

$747.03 (Jul 31)

+1.8%

$758.54 (May 28)

$725.43 (Jun 10)

*Aug 3 data reflects Jul 31 close (last available trading day). Aug 4 pre-market: APO +$3.83 / +3.0% to $129.42 (post-earnings reaction not included in table above).

Key Events Since May 6, 2026:

Valuation Context: APO trades at ~12.7x NTM P/E vs. ~16.9x 12 months ago — a 25% multiple compression that has been the primary driver of the stock’s -11% 12-month return. The 1-month performance (+9.1%) suggests the market is beginning to re-rate as private credit sentiment stabilizes and peer prints confirm the alt manager earnings cycle remains intact.

Source: Stock Price Data (Yahoo Finance); APO Stock Performance Decomposition.

6. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the July 1 pre-announcement of ~$350M in Q2 alternative net investment income — a direct positive read-through for SRE that confirms the Q1 alts headwind was largely non-recurring; the easyJet bid (Jul 20) is a secondary wildcard that could signal Apollo’s appetite for large-scale balance sheet deployment.

7. Peer Commentary & Current-Quarter Read-Throughs (Q2 2026)

Key Takeaway: Peer Q2 2026 earnings calls from Blackstone, KKR, Ares, and Blue Owl — all reporting before Apollo — paint a broadly constructive picture for Apollo’s Q2: record fundraising, robust AI infrastructure deployment, improving private credit sentiment, and strong transaction fee generation are all positive read-throughs; the primary risk is continued SRE pressure from the competitive insurance/annuity market and lingering BDC redemptions.

Note: All commentary below is strictly from Q2 2026 earnings calls or post-Q1 2026 management commentary about current-quarter (Q2 2026) conditions. No prior-quarter results commentary is included.

Blackstone (BX) — Q2 2026 Earnings Call (July 23, 2026)

Positive Read-Throughs for APO:

Risk Read-Throughs for APO:

KKR — Q2 2026 Earnings Call (July 30, 2026)

Positive Read-Throughs for APO:

Risk Read-Throughs for APO:

Ares Management (ARES) — Q2 2026 Earnings Call (July 30–31, 2026)

Positive Read-Throughs for APO:

Risk Read-Throughs for APO:

Blue Owl Capital (OWL) — Q2 2026 Earnings Call (July 30, 2026)

Positive Read-Throughs for APO:

Risk Read-Throughs for APO:

Athene Fixed Income Investor Call (May 15, 2026) — Post-Q1 Management Commentary on Q2 Conditions

Positive Read-Throughs for APO:

Risk Read-Throughs for APO:

8. Insider Transaction Activity

Key Takeaway: Only two open-market sales were identified since the Q1 earnings date — both discretionary (not 10b5-1 planned) — with Co-President John Zito selling ~$6.4M in shares and CFO Martin Kelly selling ~$0.9M; the Zito sale is notable given its size (48,644 shares) but occurred shortly after the Q1 print when the stock was near recent highs (~$131–$135), and no open-market buys were filed, which is a neutral-to-slightly-cautious signal but not alarming given the absence of clustered buying.

Name

Title

Transaction Type

Shares

Est. Value

Date

Note

John P. Zito

Co-President

Open Market Sale

48,644

~$6.4M

May 27, 2026

Discretionary; sold at ~$131–$133 range (near post-Q1 highs); retained 3,063,696 shares after sale (~94% of prior holdings). Not on a 10b5-1 plan.

Martin Kelly

Chief Financial Officer

Open Market Sale

7,000

~$0.9M

May 14, 2026

Discretionary; sold at ~$131–$135 range; retained 401,222 shares after sale. Not on a 10b5-1 plan.

No open-market buys were filed by APO insiders since the Q1 2026 earnings date. Both sales were discretionary (not 10b5-1 planned), occurred within three weeks of the Q1 print at prices near recent highs, and represent a small fraction of total holdings (Zito retained ~94% of his position). The absence of insider buying is a neutral signal; the discretionary nature of the sales warrants monitoring but is not unusual for senior executives managing concentration risk.

Source: Insider Transaction Data (SEC Form 4 Filings Database).

9. Key Questions for the Call

  1. Q2 Origination: Did you approach or exceed the record $97B quarter? What was the mix between investment-grade and sub-investment-grade, and how did spreads compare to Q1’s 350 bps over Treasuries / 290 bps over comparably rated corporates?
  2. ACS Fees: Q1 was $246M (fourth consecutive quarter above $200M). Given the Broadcom AI XPV Platform ($35B) and other large transactions, where did Q2 ACS fees land, and what is the pipeline visibility for Q3?
  3. SRE and Net Spread: The July 1 pre-announcement implied ~9% alts return vs. the 11% full-year assumption. What drove the gap (pooled vehicle at ~10% vs. other alts at ~6%), and are you still comfortable with the 120–125 bps full-year net spread guidance?
  4. Athene Inflows: April retail was $3.7B and flow reinsurance was strong. How did Q2 total Athene inflows compare to Q1’s $20B organic, and how is the new markets business ($5B+ target for 2026) tracking?
  5. ADS BDC Redemptions: Management expected elevated redemptions to persist for multiple quarters. Did Q2 redemption requests increase, decrease, or stabilize? What is the current redemption queue as a percentage of NAV?
  6. easyJet Bid: Apollo must announce a firm intention or walk away by August 7. Can you provide any color on the strategic rationale and how this fits within the balance sheet deployment framework?
  7. Daily Pricing Initiative: The June 30 deadline for daily pricing on IG corporate credit has passed. Did you achieve full implementation? What is the timeline for non-IG direct lending (previously guided to “somewhat beyond September 30”)?
  8. FY2026 Guidance: Are you reaffirming 20%+ FRE growth and 10% SRE growth? Given Q1 alts at 6% and Q2 at ~9%, what alts return is needed in H2 to hit the 11% full-year assumption, and how confident are you in achieving it?
  9. Capital Formation: Q1 included $65B from the Athora PIC acquisition. What was Q2 organic inflow composition across Asset Management and Athene, and how is the institutional vs. wealth channel mix evolving?
  10. Macro and Defensive Posture: You flagged elevated tail-risk probability at Q1. Has your macro view changed, and how is the defensive posture at Athene (holding ~$40B in cash/Treasuries) affecting near-term SRE?

Appendix: Data Sources & Citations